# FDA Inspection 1177649 - Peter Charles Klatsky M.D. Inc. - June 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/7209c018-fb25-4b9a-93ee-e9b0ec223700
Source feed: FDA_Inspections

> FDA Inspection 1177649 for Peter Charles Klatsky M.D. Inc. on June 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1177649
- Company Name: Peter Charles Klatsky M.D. Inc.
- Inspection Date: 2022-06-22
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1271002 - 2025-05-20](https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/6cf50bda-b525-498e-a244-cf8cceb7e412)
- [FDA Inspection 1271002 - 2025-05-20](https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/8365d691-2da5-491d-8004-bcd910d650c9)
- [FDA Inspection 1177649 - 2022-06-22](https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/4819b7f4-f1b9-49ff-bba1-ab8a48e06e69)
- [FDA Inspection 1177649 - 2022-06-22](https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/8b6cff39-bae5-4467-b86b-73a95c7adad5)

Company: https://www.keypedia.com/companies/peter-charles-klatsky-md-inc/dcfff450-6cf5-4d73-b955-033b40929e40

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d